Literature DB >> 28619738

Fingolimod-associated macular oedema.

Kirti Madhukar Jasani1, Nazar Sharaf2, David Rog2,2, Tariq Aslam3.   

Abstract

Entities:  

Keywords:  Drug interactions; Macula; Multiple sclerosis; Neurology (drugs and medicines); Unwanted effects / adverse reactions

Mesh：

Substances：

Year:  2017        PMID： 28619738      PMCID： PMC5534913          DOI： 10.1136/bcr-2016-218912

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


× No keyword cloud information.
  3 in total

1.  Management of fingolimod-associated macular edema.

Authors:  Jeanie Chui; Geoffrey K Herkes; Andrew Chang
Journal:  JAMA Ophthalmol       Date:  2013-05       Impact factor: 7.389

Review 2.  Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis.

Authors:  Jerold Chun; Hans-Peter Hartung
Journal:  Clin Neuropharmacol       Date:  2010 Mar-Apr       Impact factor: 1.592

3.  LETTER TO THE EDITOR Screening for Fingolimod Associated Macular Oedema: Experience Versus Guidelines.

Authors:  R Moosavi; F Bremner; J Acheson
Journal:  Open Ophthalmol J       Date:  2014-10-03
  3 in total
  2 in total

Review 1.  Ocular adverse events from pharmacological treatment in patients with multiple sclerosis-A systematic review of the literature.

Authors:  Juliana Muñoz-Ortiz; Juliana Reyes-Guanes; Estefanía Zapata-Bravo; Laura Mora-Muñoz; Juan Antonio Reyes-Hurtado; Luis Octavio Tierradentro-García; William Rojas-Carabali; Marcela Gómez-Suarez; Alejandra de-la-Torre
Journal:  Syst Rev       Date:  2021-10-28

2.  Diagnosis and Management of Fingolimod-Associated Macular Edema.

Authors:  Chunjiang Wang; Zhenzhen Deng; Liying Song; Wei Sun; Shaoli Zhao
Journal:  Front Neurol       Date:  2022-07-15       Impact factor: 4.086
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.